Category: Regulatory/FDA

Peter Pitts – Day 2 of FDA Social Media Hearing

Peter Pitts Summarizes Day 1 of FDA Social Media Hearing

Coalition and AAAA Publish Joint FDA Social Media Testimony

AAFP Defends Pharma Participation in CME

CEI Report Says FDA-DDMAC Policy Could Restrict Information for Patients

Senator Franken to Offer Rx Ad Tax Amendment. No joke.

FDA Draft Guidance: Coalition Submits Formal Comment

Coalition Asks Senate to Focus on Patient Access to Care

FDA Draft Guidance: Potentially a Significant Danger